Skip to main content
TipRanks
Go Ultimate75% OFF

Aurinia Pharmaceuticals (IKAP) Q3 2022 Earnings Report

1 Followers

DE:IKAP Q3 2022 EPS Results

Actual EPS
-EUR 0.05
Consensus EPS
-EUR 0.21
Beat/Miss
Beat by +EUR 0.15
One Year Ago EPS
-EUR 0.35

DE:IKAP Q3 2022 Revenue Results

Actual Revenue
EUR 49.62M
Expected Revenue
EUR 32.19M
Beat/Miss
Beat by +EUR 17.43M
YoY Revenue Growth
+280.30%

Earnings Announcement Details

Quarter
Q3 2022
Date
11/03/2022
Time
Before Open
Conference Call
Thursday, November 3, 2022
DE:IKAP Upcoming Earnings

Aurinia Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q3 2022 Earnings Call Audio

DE:IKAP Q3 2022 Earnings Call
0:00 / 0:00

Q3 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:IKAP Earnings History

DE:IKAP earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)0.19-1.36――
Oct 30, 20262026 (Q3)0.200.200.20.00% (+0.00)
Aug 06, 20262026 (Q2)0.210.250.1475.00% (+0.11)
May 07, 20262026 (Q1)0.170.220.1456.25% (+0.08)
Feb 26, 20262025 (Q4)0.191.360.0115200.00% (+1.35)
Nov 04, 20252025 (Q3)0.140.200.09130.00% (+0.12)
Jul 31, 20252025 (Q2)0.130.140.011500.00% (+0.13)
May 12, 20252025 (Q1)0.090.14-0.06328.57% (+0.20)
Feb 27, 20252024 (Q4)-0.010.01-0.17105.26% (+0.18)
Nov 07, 20242024 (Q3)0.010.09-0.08211.11% (+0.17)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed